Founded in 2009, Qilu Synva Pharmaceutical Co., Ltd. is currently the largest domestic base of manufacturing cephalosporin BPC for animals. Its ceftiofur and cefquinome BPCs in particular are ranking No.1 in China in terms of market share and annual production capacity. The Company offers outstanding veterinary BPCs and preparations and quality services for global animal husbandry and makes itself a world-class haute animal health brand.

Qilu Synva is a new API manufacturing base in compliance with cGMP requirements which was invested and founded by Qilu Pharmaceutical Group. In April 2013, certified in official audit in UK, the Company became the first sterile BPC manufacturer granted with EU GMP Certificate in domestic agriculture and animal husbandry.

Following the mission of “expressing our love by technology”, Qilu Synva is in pursuit of top quality driven by innovation, committed to development, manufacturing, promotion and application of quality, safe and efficient products in an attempt to become the most reliable animal health product supplier in the world and make animals live in more healthy and energetic way.